Emergent BioSolutions | Ventes



Sales Changement Date
Acadia Pharmaceuticals USD 244.32M 15.28M 2025-03
ALKERMES USD 306.5M 123.5M 2025-03
Alnylam Pharmaceuticals USD 594.19M 1.02M 2025-03
Amarin USD 42.02M 20.29M 2025-03
ANI Pharmaceuticals USD 197.1M 6.5M 2025-03
BioMarin Pharmaceutical USD 745M 2.31M 2025-03
Exact Sciences USD 707M 6.42M 2025-03
Exelixis USD 555.4M 11.35M 2025-03
Glaxosmithkline GBP 8.12B 105M 2024-12
Ionis Pharmaceuticals USD 132M 94.58M 2025-03
Ironwood Pharmaceuticals USD 90.54M 1.05M 2024-12
Lonza CHF 3.52B 460M 2024-12
Merck USD 15.53B 94M 2025-03
Moderna USD 108M 858M 2025-03
Myriad Genetics USD 195.9M 14.7M 2025-03
Neurocrine Biosciences USD 572.6M 55.1M 2025-03
Pacira USD 168.92M 18.33M 2025-03
Pfizer USD 13.72B 4.04B 2025-03
PTC Therapeutics USD 190M 23.17M 2025-03
Sanofi EUR 9.9B 660M 2025-03
Sarepta Therapeutics USD 774.9M 116.49M 2025-03
United Therapeutics USD 794.4M 58.5M 2025-03



Emergent BioSolutions Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.